R3HDML
gene geneOn this page
Also known as dJ881L22.3
Summary
R3HDML (R3H domain containing like, HGNC:16249) is a protein-coding gene on chromosome 20q13.12, encoding Peptidase inhibitor R3HDML (Q9H3Y0). Putative serine protease inhibitor.
Predicted to enable peptidase inhibitor activity. Predicted to be located in extracellular region. Predicted to be active in extracellular space.
Source: NCBI Gene 140902 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 45 total — 1 pathogenic
- MANE Select transcript:
NM_178491
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16249 |
| Approved symbol | R3HDML |
| Name | R3H domain containing like |
| Location | 20q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ881L22.3 |
| Ensembl gene | ENSG00000101074 |
| Ensembl biotype | protein_coding |
| Entrez | 140902 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000217043
RefSeq mRNA: 1 — MANE Select: NM_178491
NM_178491
CCDS: CCDS13329
Canonical transcript exons
ENST00000217043 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000662232 | 44337043 | 44337418 |
| ENSE00000662233 | 44341196 | 44341314 |
| ENSE00000662234 | 44343377 | 44343509 |
| ENSE00000662235 | 44345263 | 44345378 |
| ENSE00000844865 | 44350660 | 44351238 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 95.55.
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.55 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 66.11 | gold quality |
| right uterine tube | UBERON:0001302 | 63.95 | gold quality |
| rectum | UBERON:0001052 | 60.30 | gold quality |
| colonic epithelium | UBERON:0000397 | 56.11 | gold quality |
| transverse colon | UBERON:0001157 | 55.40 | gold quality |
| duodenum | UBERON:0002114 | 54.61 | gold quality |
| small intestine | UBERON:0002108 | 48.11 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 47.89 | gold quality |
| right lobe of liver | UBERON:0001114 | 45.43 | gold quality |
| liver | UBERON:0002107 | 44.39 | silver quality |
| intestine | UBERON:0000160 | 44.18 | gold quality |
| sural nerve | UBERON:0015488 | 43.47 | gold quality |
| colon | UBERON:0001155 | 42.64 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 40.16 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 40.05 | gold quality |
| kidney | UBERON:0002113 | 39.07 | gold quality |
| endocervix | UBERON:0000458 | 37.46 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| fallopian tube | UBERON:0003889 | 35.12 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.81 | gold quality |
| cortex of kidney | UBERON:0001225 | 33.76 | gold quality |
| muscle tissue | UBERON:0002385 | 33.28 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| hypothalamus | UBERON:0001898 | 32.04 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| stomach | UBERON:0000945 | 30.40 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
47 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | r3hdml | ENSDARG00000030650 |
| mus_musculus | R3hdml | ENSMUSG00000078949 |
| rattus_norvegicus | R3hdml | ENSRNOG00000027432 |
| drosophila_melanogaster | Ag5r | FBGN0015010 |
| drosophila_melanogaster | Ag5r2 | FBGN0020508 |
| drosophila_melanogaster | CG9400 | FBGN0030562 |
| drosophila_melanogaster | CG10651 | FBGN0032853 |
| drosophila_melanogaster | CG9822 | FBGN0034623 |
| drosophila_melanogaster | CG17974 | FBGN0034624 |
| drosophila_melanogaster | CG3640 | FBGN0035042 |
| drosophila_melanogaster | CG8072 | FBGN0036070 |
| drosophila_melanogaster | CG6628 | FBGN0036072 |
| drosophila_melanogaster | scpr-C | FBGN0037879 |
| drosophila_melanogaster | scpr-B | FBGN0037888 |
| drosophila_melanogaster | scpr-A | FBGN0037889 |
| drosophila_melanogaster | CG8483 | FBGN0038126 |
| drosophila_melanogaster | CG30486 | FBGN0050486 |
| drosophila_melanogaster | antr | FBGN0050488 |
| drosophila_melanogaster | CG31286 | FBGN0051286 |
| drosophila_melanogaster | CG32313 | FBGN0052313 |
| drosophila_melanogaster | CG32679 | FBGN0052679 |
| drosophila_melanogaster | CG34002 | FBGN0054002 |
| drosophila_melanogaster | CG17575 | FBGN0250842 |
| drosophila_melanogaster | CG42564 | FBGN0260766 |
| drosophila_melanogaster | CG42780 | FBGN0261848 |
| drosophila_melanogaster | CG43775 | FBGN0264297 |
| drosophila_melanogaster | CG43776 | FBGN0264298 |
| drosophila_melanogaster | CG43777 | FBGN0264299 |
| caenorhabditis_elegans | WBGENE00004742 | |
| caenorhabditis_elegans | WBGENE00007397 | |
| caenorhabditis_elegans | WBGENE00008027 | |
| caenorhabditis_elegans | WBGENE00008028 | |
| caenorhabditis_elegans | WBGENE00008029 | |
| caenorhabditis_elegans | WBGENE00008030 | |
| caenorhabditis_elegans | WBGENE00008625 | |
| caenorhabditis_elegans | WBGENE00009891 | |
| caenorhabditis_elegans | WBGENE00009895 | |
| caenorhabditis_elegans | WBGENE00009896 | |
| caenorhabditis_elegans | WBGENE00012816 | |
| caenorhabditis_elegans | WBGENE00013971 | |
| caenorhabditis_elegans | WBGENE00013972 | |
| caenorhabditis_elegans | WBGENE00015246 | |
| caenorhabditis_elegans | WBGENE00017055 | |
| caenorhabditis_elegans | WBGENE00017183 | |
| caenorhabditis_elegans | WBGENE00019178 | |
| caenorhabditis_elegans | WBGENE00019179 | |
| caenorhabditis_elegans | WBGENE00021780 |
Paralogs (13): CRISP3 (ENSG00000096006), CRISPLD2 (ENSG00000103196), CRISPLD1 (ENSG00000121005), GLIPR2 (ENSG00000122694), CRISP2 (ENSG00000124490), CRISP1 (ENSG00000124812), PI15 (ENSG00000137558), GLIPR1 (ENSG00000139278), CLEC18B (ENSG00000140839), CLEC18A (ENSG00000157322), CLEC18C (ENSG00000157335), GLIPR1L1 (ENSG00000173401), GLIPR1L2 (ENSG00000180481)
Protein
Protein identifiers
Peptidase inhibitor R3HDML — Q9H3Y0 (reviewed: Q9H3Y0)
Alternative names: Cysteine-rich secretory protein R3HDML
All UniProt accessions (1): Q9H3Y0
UniProt curated annotations — full annotation on UniProt →
Function. Putative serine protease inhibitor.
Subcellular location. Secreted.
Similarity. Belongs to the CRISP family.
RefSeq proteins (1): NP_848586* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001283 | CRISP-related | Family |
| IPR014044 | CAP_dom | Domain |
| IPR035940 | CAP_sf | Homologous_superfamily |
| IPR047899 | R3HDML_CAP | Domain |
Pfam: PF00188
UniProt features (7 total): sequence variant 2, signal peptide 1, propeptide 1, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H3Y0-F1 | 83.15 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 120
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
GOMF_PEPTIDASE_REGULATOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS, GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY, CTTTGA_LEF1_Q2, GOMF_PEPTIDASE_INHIBITOR_ACTIVITY, TGCCAAR_NF1_Q6, SMAD3_Q6, chr20q13, GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP, GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP, GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN, GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP, GATTGGY_NFY_Q6_01
GO Biological Process (0):
GO Molecular Function (1): peptidase inhibitor activity (GO:0030414)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| R3HDML | FITM2 | Q8N6M3 | 775 |
| R3HDML | KCNK16 | Q96T55 | 654 |
| R3HDML | ZFAND3 | Q9H8U3 | 621 |
| R3HDML | GCC1 | Q96CN9 | 609 |
| R3HDML | MAEA | Q7L5Y9 | 596 |
| R3HDML | PSMD6 | Q15008 | 593 |
| R3HDML | PEPD | P12955 | 507 |
| R3HDML | GLIS3 | Q8NEA6 | 507 |
| R3HDML | C2CD4A | Q8NCU7 | 506 |
| R3HDML | CDC123 | O75794 | 476 |
| R3HDML | C2CD4B | A6NLJ0 | 447 |
| R3HDML | PAX4 | O43316 | 447 |
| R3HDML | C3orf22 | Q8N5N4 | 434 |
| R3HDML | BTBD17 | A6NE02 | 423 |
| R3HDML | OPTC | Q9UBM4 | 417 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| R3HDML | PLEC | psi-mi:“MI:0915”(physical association) | 0.400 |
| R3HDML | CDK7 | psi-mi:“MI:0915”(physical association) | 0.400 |
| R3HDML | HSPA5 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (4): R3HDML (Proximity Label-MS), CDK7 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), APP (Reconstituted Complex)
ESM2 similar proteins: A0A0D3QS98, A0A0D3QS99, A2A5I3, O19010, O19011, O42596, P01137, P04202, P04629, P07200, P09533, P16562, P17246, P18341, P35739, P50414, P54108, P54831, P57110, Q01974, Q38HS2, Q3KPV7, Q3UFB7, Q505J3, Q5R7Y0, Q5T4F7, Q60477, Q658N2, Q6UWX4, Q7T141, Q7TSQ1, Q80XH4, Q8BG58, Q91009, Q99JR5, Q9CXM0, Q9D2G9, Q9EQT5, Q9GZM7, Q9H3Y0
Diamond homologs: A0A218QX58, A1BQQ5, A5D8T8, A6YPK1, A8S6B6, B0VXV6, B2MVK7, B7FDI0, B7FDI1, C0ITL3, D4P2Y4, D8VNS1, F7C0L1, F8J2D4, G3CJR9, O19010, P0DMB9, P0DMT4, P0DPU0, P0DSI3, P10736, P10737, P11670, P16562, P16563, P35759, P35778, P35779, P35780, P35781, P35782, P35783, P35785, P35786, P35787, P36110, P47032, P54108, P60623, P79845
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 979733 | GRCh37/hg19 20q13.12(chr20:42778133-43079191)x1 | Pathogenic |
SpliceAI
695 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:44337415:CATGG:C | donor_loss | 1.0000 |
| 20:44337416:ATGG:A | donor_loss | 1.0000 |
| 20:44337417:TGGTG:T | donor_loss | 1.0000 |
| 20:44337418:GGTG:G | donor_loss | 1.0000 |
| 20:44337419:G:GC | donor_loss | 1.0000 |
| 20:44337419:G:GG | donor_gain | 1.0000 |
| 20:44337420:T:G | donor_loss | 1.0000 |
| 20:44341310:GGCCA:G | donor_gain | 1.0000 |
| 20:44341311:GCCA:G | donor_gain | 1.0000 |
| 20:44341311:GCCAG:G | donor_gain | 1.0000 |
| 20:44341315:G:GG | donor_gain | 1.0000 |
| 20:44345375:T:TG | donor_gain | 1.0000 |
| 20:44345379:G:GG | donor_gain | 1.0000 |
| 20:44337415:CATG:C | donor_gain | 0.9900 |
| 20:44337416:ATG:A | donor_gain | 0.9900 |
| 20:44337417:TG:T | donor_gain | 0.9900 |
| 20:44337418:GG:G | donor_gain | 0.9900 |
| 20:44337421:GAG:G | donor_loss | 0.9900 |
| 20:44341312:CCA:C | donor_gain | 0.9900 |
| 20:44341312:CCAG:C | donor_loss | 0.9900 |
| 20:44341313:CAG:C | donor_loss | 0.9900 |
| 20:44341314:AGT:A | donor_loss | 0.9900 |
| 20:44341315:GT:G | donor_loss | 0.9900 |
| 20:44341316:TGAG:T | donor_loss | 0.9900 |
| 20:44341317:G:GC | donor_loss | 0.9900 |
| 20:44341318:AGTGA:A | donor_loss | 0.9900 |
| 20:44341319:G:A | donor_loss | 0.9900 |
| 20:44345261:A:AG | acceptor_gain | 0.9900 |
| 20:44345261:AGAT:A | acceptor_gain | 0.9900 |
| 20:44345262:G:GG | acceptor_gain | 0.9900 |
AlphaMissense
1670 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:44341201:G:C | W89C | 0.993 |
| 20:44341201:G:T | W89C | 0.993 |
| 20:44345362:T:A | C205S | 0.985 |
| 20:44345363:G:C | C205S | 0.985 |
| 20:44345293:T:A | C182S | 0.983 |
| 20:44345294:G:C | C182S | 0.983 |
| 20:44345271:G:C | W174C | 0.982 |
| 20:44345271:G:T | W174C | 0.982 |
| 20:44337399:C:A | A81D | 0.981 |
| 20:44341244:T:A | C104S | 0.981 |
| 20:44341245:G:C | C104S | 0.981 |
| 20:44345279:C:T | S177F | 0.979 |
| 20:44341224:C:A | A97D | 0.977 |
| 20:44341199:T:A | W89R | 0.976 |
| 20:44341199:T:C | W89R | 0.976 |
| 20:44341223:G:C | A97P | 0.976 |
| 20:44341291:G:C | Q119H | 0.976 |
| 20:44341291:G:T | Q119H | 0.976 |
| 20:44345363:G:A | C205Y | 0.976 |
| 20:44341234:G:C | W100C | 0.974 |
| 20:44341234:G:T | W100C | 0.974 |
| 20:44343509:G:C | Q171H | 0.974 |
| 20:44343509:G:T | Q171H | 0.974 |
| 20:44350751:T:A | C241S | 0.974 |
| 20:44350752:G:C | C241S | 0.974 |
| 20:44341203:A:T | D90V | 0.972 |
| 20:44345290:G:T | G181C | 0.972 |
| 20:44345296:G:C | A183P | 0.971 |
| 20:44350685:T:G | Y219D | 0.970 |
| 20:44341252:G:C | W106C | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000027733 (20:44350126 T>A), RS1000100840 (20:44351027 G>C), RS1000102731 (20:44350103 A>C,G), RS1000174398 (20:44340454 A>G), RS1000250547 (20:44344648 T>C), RS1000304322 (20:44344927 G>A,C), RS1000461972 (20:44345929 C>G,T), RS1000464048 (20:44339227 A>G), RS1000557681 (20:44351332 C>T), RS1000594349 (20:44346185 A>G), RS1000646766 (20:44346523 A>C,G), RS1000672316 (20:44340075 C>A,T), RS1000758636 (20:44340174 C>T), RS1000798613 (20:44347228 T>C), RS1001062337 (20:44335301 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001351_6 | Type 2 diabetes | 1.000000e-11 |
| GCST003264_896 | Post bronchodilator FEV1/FVC ratio | 5.000000e-06 |
| GCST007483_44 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 1.000000e-07 |
| GCST007487_31 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 1.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004713 | FEV/FVC ratio |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases methylation, increases mutagenesis | 2 |
| terbufos | increases methylation | 1 |
| Acetaminophen | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.